FDL176 & FDL169 coadministration
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Flatley Discovery Lab LLC
Overview
FDL176 & FDL169 coadministration is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
FDL176 & FDL169 coadministration clinical trials
Explore related
Medical disclaimer. This page summarizes research about FDL176 & FDL169 coadministration for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.